Highlights Gerresheimer AG

Equities

Real-time Estimate Tradegate Other stock markets 07:08:08 2024-05-21 am EDT			5-day change	1st Jan Change
96.75 ^EUR	-1.68%		-3.68%	+2.60%

May. 16	GERRESHEIMER AG : UBS reiterates its Buy rating	ZD
May. 15	Schott Pharma falls sharply - 'High dependence on end markets'	DP

Schott Pharma falls sharply - 'High dependence on end markets'	May. 15	DP
Schott Pharma warns of weak syringe sales - share price slide	May. 15	DP
Gerresheimer AG acquired minority stake in RxCap Inc.	Apr. 28	CI
Gerresheimer shares down on outlook, but key contracts confirmed	Apr. 11	RE
Barclays upgrades Gerresheimer to 'Overweight' - Target 125 euros	Apr. 11	DP
Gerresheimer continues to focus on recovery from the summer - share price falls	Apr. 11	DP
Gerresheimer very weak - Certain uncertainties about outlook	Apr. 11	DP
Gerresheimer supplies 'key players' in GLP-1 drugs market, CEO says	Apr. 11	RE
Gerresheimer expects sales boost from burgeoning obesity drugs sector	Apr. 11	RE
Partially lower pharmaceutical demand slows down Gerresheimer - outlook confirmed	Apr. 11	DP
Gerresheimer AG Provides Earnings Guidance for the Year 2024 and 2025	Apr. 11	CI
Gerresheimer AG Reports Earnings Results for the First Quarter Ended February 29, 2024	Apr. 10	CI
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	Mar. 29	RE
Gerresheimer under pressure - First quarter weak as announced	Mar. 26	DP
Dpa-AFX Overview: COMPANIES from 22.02.2024 - 15:15	Feb. 22	DP
Gerresheimer with liberating blow - convincing business outlook	Feb. 22	DP
Gerresheimer expects less growth in 2024 - dividend stable	Feb. 22	DP
Jefferies rates Gerresheimer a 'Buy' - Target 120 euros	Feb. 22	DP
Gerresheimer Ag Proposes Dividend for the Year 2023	Feb. 22	CI
Gerresheimer AG Reports Earnings Results for the Full Year Ended November 30, 2023	Feb. 21	CI

No results for this search